![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_usWZ6PnniZel_PiMEqnW733EiPCRSx5xAL7wcsLAkyjNdqHskOUrchP4Cn5__uFBySPs7pPMaqYOINgv35UNUi9cyZghpURySN1i8EVRI=s0-d){kind=small}
Public release date: 6-Aug-2012[ | E-mail |
Share ] Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University
The primary aim of the study is to investigate the efficacy of acupuncture/moxibustion in reducing abdominal pain/discomfort
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
The primary aim of the study is to investigate the efficacy of Acupuncture/Moxibustion (Acu/Moxa) in reducing abdominal pain/discomfort and IBS secondary supporting symptoms such as intestinal gas, bloating, and stool consistency. The randomized, blinded, sham/placebo controlled study, with 183 adults diagnosed with IBS-Constipation, will follow the accepted standards of rigorous clinical trials.
"Acu/Moxa , used in traditional Chinese medicine, has been employed successfully to manage various GI disorders including IBS," said Dr. Anastasi. "However, few acupuncture studies have had the necessary rigor to evaluate this therapy," she said.
IBS is the most commonly identified functional bowel disorder afflicting 15% to 20% of North Americans. IBS is defined as abdominal pain/discomfort in the mid or lower gastrointestinal (GI) tract, associated with defecation or a change in bowel patterns with features of disordered defecation.
The chronic symptoms of IBS have been linked with decreased quality of life, decreased work productivity, and increased health care utilization. Few current therapies such as dietary modification, supplements, psychotherapy and pharmacologic agents are proven effective, either singly or in combination. Most [studies] said Dr. Anastasi, "have been limited by size, design and duration of follow-up."
Dr. Anastasi is one of the country's leading clinical scientists in the area of symptom management. Over the past three years, Dr. Anastasi has been awarded three NIH R01s, all of which have contributed to developing rigorously tested, randomized clinical trials using non-invasive interventions to manage chronic and often debilitating symptoms. Her studies provide the foundation to develop clinically meaningful interventions to guide researchers, clinicians and patients to understand the therapeutic benefits of methods such as traditional Chinese medicine.
Dr. Anastasi served on the Advisory Board for the Institute of Medicine's (IOM) report on The Use of Complementary and Alternative Medicine by the American Public. Dr. Anastasi, a nurse scientist, clinical trialist is also an acupuncturist, Diplomate from the NCCAOM. Dr. Anastasi authored and developed the Herbs, Nutraceuticals and Dietary Supplements graduate program funded by the Health Resources and Services Administration (HRSA). She has published extensively in the area of symptom management using non-invasive interventions and has received numerous awards for her contributions and expertise in acupuncture and symptom management research.
###
About The Division of Special Studies in Symptom Management (DS3M) is led by founding director, Joyce K. Anastasi, PhD, DrNP, FAAN, LAc, and associate director Bernadette Capili, DNSc, NP-C. DS3M aims to provide a comprehensive site for multidisciplinary scientific inquiry, clinical research, and educational training in the area of symptom management.
The mission of DS3M is to advance the field of symptom management by developing and testing non-invasive treatment interventions that improve overall health, reduce symptom specific problems, promote long-term health, prevent disease and improve quality of life. To date, the Division of Special Studies research team has tested symptom reduction strategies for peripheral neuropathy, lipodystrophy, chronic nausea, chronic diarrhea, and irritable bowel syndrome. Non-invasive interventions tested and utilized include behavioral training, motivational interviewing, nutritional education, controlled dietary feeding, dietary supplementation and the Traditional Chinese Medicine practices of acupuncture and moxibustion.
About NYU College of Nursing: NYUCN is a global leader in nursing education, research, and practice. It offers a Bachelor of Science in Nursing; Master of Arts and Post-Master's Certificate Programs; a Doctor of Nursing Practice degree; and a Doctor of Philosophy in Research Theory and Development. For more information, visit www.nyu.edu/nursing.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 6-Aug-2012[ | E-mail |
Share ] Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University
The primary aim of the study is to investigate the efficacy of acupuncture/moxibustion in reducing abdominal pain/discomfort
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
The primary aim of the study is to investigate the efficacy of Acupuncture/Moxibustion (Acu/Moxa) in reducing abdominal pain/discomfort and IBS secondary supporting symptoms such as intestinal gas, bloating, and stool consistency. The randomized, blinded, sham/placebo controlled study, with 183 adults diagnosed with IBS-Constipation, will follow the accepted standards of rigorous clinical trials.
"Acu/Moxa , used in traditional Chinese medicine, has been employed successfully to manage various GI disorders including IBS," said Dr. Anastasi. "However, few acupuncture studies have had the necessary rigor to evaluate this therapy," she said.
IBS is the most commonly identified functional bowel disorder afflicting 15% to 20% of North Americans. IBS is defined as abdominal pain/discomfort in the mid or lower gastrointestinal (GI) tract, associated with defecation or a change in bowel patterns with features of disordered defecation.
The chronic symptoms of IBS have been linked with decreased quality of life, decreased work productivity, and increased health care utilization. Few current therapies such as dietary modification, supplements, psychotherapy and pharmacologic agents are proven effective, either singly or in combination. Most [studies] said Dr. Anastasi, "have been limited by size, design and duration of follow-up."
Dr. Anastasi is one of the country's leading clinical scientists in the area of symptom management. Over the past three years, Dr. Anastasi has been awarded three NIH R01s, all of which have contributed to developing rigorously tested, randomized clinical trials using non-invasive interventions to manage chronic and often debilitating symptoms. Her studies provide the foundation to develop clinically meaningful interventions to guide researchers, clinicians and patients to understand the therapeutic benefits of methods such as traditional Chinese medicine.
Dr. Anastasi served on the Advisory Board for the Institute of Medicine's (IOM) report on The Use of Complementary and Alternative Medicine by the American Public. Dr. Anastasi, a nurse scientist, clinical trialist is also an acupuncturist, Diplomate from the NCCAOM. Dr. Anastasi authored and developed the Herbs, Nutraceuticals and Dietary Supplements graduate program funded by the Health Resources and Services Administration (HRSA). She has published extensively in the area of symptom management using non-invasive interventions and has received numerous awards for her contributions and expertise in acupuncture and symptom management research.
###
About The Division of Special Studies in Symptom Management (DS3M) is led by founding director, Joyce K. Anastasi, PhD, DrNP, FAAN, LAc, and associate director Bernadette Capili, DNSc, NP-C. DS3M aims to provide a comprehensive site for multidisciplinary scientific inquiry, clinical research, and educational training in the area of symptom management.
The mission of DS3M is to advance the field of symptom management by developing and testing non-invasive treatment interventions that improve overall health, reduce symptom specific problems, promote long-term health, prevent disease and improve quality of life. To date, the Division of Special Studies research team has tested symptom reduction strategies for peripheral neuropathy, lipodystrophy, chronic nausea, chronic diarrhea, and irritable bowel syndrome. Non-invasive interventions tested and utilized include behavioral training, motivational interviewing, nutritional education, controlled dietary feeding, dietary supplementation and the Traditional Chinese Medicine practices of acupuncture and moxibustion.
About NYU College of Nursing: NYUCN is a global leader in nursing education, research, and practice. It offers a Bachelor of Science in Nursing; Master of Arts and Post-Master's Certificate Programs; a Doctor of Nursing Practice degree; and a Doctor of Philosophy in Research Theory and Development. For more information, visit www.nyu.edu/nursing.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2012-08/nyu-nco080612.php
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.